Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GUSB pseudogene 3 (GUSBP3) is a human pseudogene, meaning it is a non-functional segment of DNA that resembles the functional GUSB gene (which encodes the enzyme beta-glucuronidase)[5]. Unlike functional genes, pseudogenes such as GUSBP3 generally do not encode active proteins and do not play direct biological or disease roles. The functional GUSB gene is involved in lysosomal degradation of glycosaminoglycans, and mutations in GUSB (not GUSBP3) are implicated in metabolic disorders like mucopolysaccharidosis type VII[1][2][4]. GUSBP3 is sometimes also referenced as GUSBP1 or by other aliases but has not been shown to perform any enzymatic activity or serve as a therapeutic target. No drugs, biomarkers, or known safety concerns are associated with GUSBP3, and it is not recognized as a druggable or clinically actionable target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GUSB pseudogene 3 (GUSBP3).